Reaction Details |
| Report a problem with these data |
Target | Alpha-2B adrenergic receptor |
---|
Ligand | BDBM50241196 |
---|
Substrate/Competitor | n/a |
---|
Ki | 19.4984±n/a nM |
---|
Comments | PDSP_3304 |
---|
Citation | Millan, MJ; Dekeyne, A; Newman-Tancredi, A; Cussac, D; Audinot, V; Milligan, G; Duqueyroix, D; Girardon, S; Mullot, J; Boutin, JA; Nicolas, JP; Renouard-Try, A; Lacoste, JM; Cordi, A S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther295:1192-205 (2000) [PubMed] |
---|
More Info.: | Get all data from this article |
---|
|
Alpha-2B adrenergic receptor |
---|
Name: | Alpha-2B adrenergic receptor |
Synonyms: | ADA2B_HUMAN | ADRA2B | ADRA2L1 | ADRA2RL1 | Adrenergic alpha2B | Adrenergic receptor | Adrenergic receptor alpha | Adrenergic, alpha-2B-, receptor [Homo sapiens] | Alpha-2 adrenergic receptor subtype C2 | Alpha-2B adrenoceptor | Alpha-2B adrenoreceptor | Alpha-2BAR |
Type: | Enzyme |
Mol. Mass.: | 49964.20 |
Organism: | Homo sapiens (Human) |
Description: | P18089 |
Residue: | 450 |
Sequence: | MDHQDPYSVQATAAIAAAITFLILFTIFGNALVILAVLTSRSLRAPQNLFLVSLAAADIL
VATLIIPFSLANELLGYWYFRRTWCEVYLALDVLFCTSSIVHLCAISLDRYWAVSRALEY
NSKRTPRRIKCIILTVWLIAAVISLPPLIYKGDQGPQPRGRPQCKLNQEAWYILASSIGS
FFAPCLIMILVYLRIYLIAKRSNRRGPRAKGGPGQGESKQPRPDHGGALASAKLPALASV
ASAREVNGHSKSTGEKEEGETPEDTGTRALPPSWAALPNSGQGQKEGVCGASPEDEAEEE
EEEEEEEEECEPQAVPVSPASACSPPLQQPQGSRVLATLRGQVLLGRGVGAIGGQWWRRR
AQLTREKRFTFVLAVVIGVFVLCWFPFFFSYSLGAICPKHCKVPHGLFQFFFWIGYCNSS
LNPVIYTIFNQDFRRAFRRILCRPWTQTAW
|
|
|
BDBM50241196 |
---|
n/a |
---|
Name | BDBM50241196 |
Synonyms: | (R)-5-(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole | 4-[(R)-1-(2,3-Dimethyl-phenyl)-ethyl]-1H-imidazole | CHEMBL397901 | Dexmedetomidine |
Type | Small organic molecule |
Emp. Form. | C13H16N2 |
Mol. Mass. | 200.2795 |
SMILES | C[C@@H](c1cnc[nH]1)c1cccc(C)c1C |
Structure |
|